Mesenchymal Stem/Stromal Cell Therapies: Innovations in Regenerative Medicine and Translational Applications
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Stem Cells".
Deadline for manuscript submissions: 20 April 2026 | Viewed by 208
Special Issue Editors
Interests: hematopoietic cells; human mesenchymal stromal/stem cells (MSCs); regenerative medicine; T, B and NK lymphocytes
Special Issue Information
Dear Colleagues,
Human mesenchymal stem/stromal cells (hMSCs), as has been known for years, have extraordinary differentiation potential toward various lineages, namely adipogenic, chondrogenic, and osteogenic, as well as hepatic and pancreatic. Furthermore, their immunomodulatory properties make them a promising tool for application in the field of regenerative medicine. Based on extensive in vitro evidence, the immunological effects of MSCs on immune cells may depend on various mechanisms, such as cell-to-cell contact and paracrine signaling. MSCs also release exosomes capable of exerting various effects in a paracrine manner, influencing inflammatory processes.
This Special Issue of Cells will highlight the cell biology and immunology of MSCS through original research articles, reviews, and communications.
Dr. Giandomenico Amico
Dr. Paolo Elia Cappella
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- mesenchymal stem cells (MSCs)
- stromal cells
- microvesicles
- exosomes
- extracellular vesicles (EVs)
- immunomodulatory properties
- bone marrow
- adipose tissue
- Wharton’s jelly
- cord blood
- placenta
- amnion
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
